NCT05071482 2025-05-01Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALLInstitute of Hematology & Blood Diseases Hospital, ChinaPhase 4 Terminated39 enrolled
NCT04677439 2022-03-16Flumatinib in CML-CP Patients With Ph+ Post Imatinib FailureShenzhen Second People's HospitalPhase 4 Unknown200 enrolled